Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Three novel FHL1 Variants cause a mild Phenotype of Emery-Dreifuss Muscular Dystrophy

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Constitutional POLE variants causing a phenotype reminiscent of constitutional mismatch repair deficiency

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Myopathy can be a key phenotype of membrin (GOSR2) deficiency

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. Expansion of the phenotypic spectrum of de novo missense variants in kinesin family member 1A (KIF1A)

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. Causes of symptom dissatisfaction in patients with generalized myasthenia gravis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Novel Homozygous Truncating Variant Widens the Spectrum of Early-Onset Multisystemic SYNE1 Ataxia

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. High Resolution Analysis of DMPK Hypermethylation and Repeat Interruptions in Myotonic Dystrophy Type 1

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

Emery-Dreifuss muscular dystrophy (EDMD) is a hereditary muscle disease, characterized by the clinical triade of early-onset joint contractures, progressive muscle weakness and cardiac involvement. Pathogenic variants in FHL1 can cause a rare X-linked recessive form of EDMD, type 6. We report three men with novel variants in FHL1 leading to EDMD6. Onset of muscle symptoms was in late adulthood and muscle weakness was not prominent in either of the patients. All patients had hypertrophic cardiomyopathy and one of them also had cardiac arrhythmias. Western blot performed on muscle biopsies from two of the patients showed no FHL1 protein expression. We predict that the variant in the third patient also leads to absence of FHL1 protein. Complete loss of all FHL1 isoforms combined with mild muscle involvement supports the hypothesis that loss of all FHL1 isoforms is more benign than the cytotoxic effects of expressed FHL1 protein with pathogenic missense variants. This article is protected by copyright. All rights reserved.

OriginalsprogEngelsk
TidsskriftHuman Mutation
ISSN1059-7794
DOI
StatusE-pub ahead of print - 24 maj 2022

Bibliografisk note

This article is protected by copyright. All rights reserved.

ID: 78264971